Skip to Content
Merck
  • A glucose meter interface for point-of-care gene circuit-based diagnostics.

A glucose meter interface for point-of-care gene circuit-based diagnostics.

Nature communications (2021-02-03)
Evan Amalfitano, Margot Karlikow, Masoud Norouzi, Katariina Jaenes, Seray Cicek, Fahim Masum, Peivand Sadat Mousavi, Yuxiu Guo, Laura Tang, Andrew Sydor, Duo Ma, Joel D Pearson, Daniel Trcka, Mathieu Pinette, Aruna Ambagala, Shawn Babiuk, Bradley Pickering, Jeff Wrana, Rod Bremner, Tony Mazzulli, David Sinton, John H Brumell, Alexander A Green, Keith Pardee
ABSTRACT

Recent advances in cell-free synthetic biology have given rise to gene circuit-based sensors with the potential to provide decentralized and low-cost molecular diagnostics. However, it remains a challenge to deliver this sensing capacity into the hands of users in a practical manner. Here, we leverage the glucose meter, one of the most widely available point-of-care sensing devices, to serve as a universal reader for these decentralized diagnostics. We describe a molecular translator that can convert the activation of conventional gene circuit-based sensors into a glucose output that can be read by off-the-shelf glucose meters. We show the development of new glucogenic reporter systems, multiplexed reporter outputs and detection of nucleic acid targets down to the low attomolar range. Using this glucose-meter interface, we demonstrate the detection of a small-molecule analyte; sample-to-result diagnostics for typhoid, paratyphoid A/B; and show the potential for pandemic response with nucleic acid sensors for SARS-CoV-2.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glucose dehydrogenase from Pseudomonas sp., powder, white, ≥200 U/mg
Roche
CPRG, Chlorophenol red-β-D-galactopyranoside